Fifty-third ACBTSA Meeting: August 17-18, 2021

August 17, 2021 - August 18, 2021

During this meeting, the committee will discuss issues pertaining to data collection infrastructure to track blood availability and utilization, and improvements to the supply chain to improve resiliency. In order to facilitate these discussions, key stakeholders from across the nation and around the world will present on hemovigilance, preparedness, inventory management systems and other relevant issues.


Webcast Link

To view the webcast of the meeting, please go to https://www.hhs.gov/live/index.html at the date and time of the meeting.


Public Comment - Information and Instructions

The public will have an opportunity to present their views to the ACBTSA during the meeting's public comment session or by submitting their views in writing. Comments should be pertinent to the meeting discussion.

Verbal Public Comment:

Verbal remarks will be provided by the public over the phone during the live webcast and become part of the archived recording and meeting summary posted on this website.

Date and time: Tuesday, August 17 (Exact time forthcoming)

To sign-up for verbal public comment:

  • Submit an email request to [email protected]
  • Use the email subject line: Verbal Public Comment – August 17
  • Deadline: All sign-up requests must be received by 11:59 p.m., ET, Monday, August 9

Next steps: If more requests to provide verbal public comment are received than can be accommodated during this meeting, speakers will be randomly selected. You will receive notification on the status of your request on Thursday, August 12.

  • If you are selected to provide verbal public comment at the meeting, you will be asked to confirm that you are still available to speak during the assigned time. Upon confirmation, you will receive a call-in number and time to provide your comment. Each person will be limited to 3 minutes in order to accommodate as many speakers as possible. If you are no longer able to provide verbal public comment, HHS will randomly select another speaker.
  • If you are not selected, you are welcome to submit your name for consideration in a future meeting of the Advisory Committee once the meeting information is posted.

Written Public Comment:

Written public comments are shared with Advisory Committee members and posted on this webpage and made accessible to the public in advance of the meeting.

To submit a written public comment:

  • Submit an email to [email protected]
  • Use the email subject line: Written Public Comment – August 17
  • Deadline: All written comments must be received by 11:59 p.m., ET, Monday, August 9
  • Provide your preferred identification: Tell us how you prefer to be identified with your comment. We cannot post your comment without this information. You may choose one or more of the following options:
    • Use your name
    • Be listed as anonymous
    • Include your city and/or state
    • Provide comments on behalf of an organization (please include the organization's full name)

Writing your public comment:

  • Format: Comments must be in the body of your email or in an attached Word document.
  • Page Limit: Comments must not exceed four (4) pages in Calibri or Times New Roman, 11 point font (text that exceeds four pages will be deleted).
  • Graphics: Do not include graphics, images, text boxes, or tables. If included, they will not be retained.
  • Links: Hyperlinks will only be added for ".gov" sites (local, state, or federal). For all other reference sites, please insert the full URL (e.g., http://learn.genetics.utah.edu/content/epigenetics).
  • Attachments: Do not include any attachments. We are also unable to include attachments as supporting documentation to written comments.

Next steps: Your written comment will be posted to this website before the meeting. If you have any questions or concerns about submitting your comment, contact us at [email protected]

Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed